[1] |
XU Yiqi, WU Qian, LIU Shu, LIU Fan, XING Chunyan, LI Qin, HE Junjun, HE Chunling, ZHAO Yongli, GAO Jialin.
Clinical efficacy and anti-inflammation/anti-fibrosis effect of tripterygium glycosides in the treatment of diabetic nephropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1034-1042.
|
[2] |
WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan.
Research progress on diagnosis and treatment of granulomatous lobular mastitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 910-917.
|
[3] |
ZHONG Wei, SHI Shuxia, QIN Qinyue, YU Guo.
Measurement tools and rationality evaluation of clinical research coordinator's work ability and workload
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 937-947.
|
[4] |
ZHANG Taotao, SU Wenxiu, TIAN Limin.
Research progress on the relationship between subclinical hypothyroidism and depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 954-960.
|
[5] |
WANG Anjing, WANG Yaya, LIANG Xuan, YAN Yajie, SU Jing, LI Caidong.
Research progress on mechanisms and therapeutic drugs of peroxisome proliferator-activated receptor in treatment of cholestatic liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 796-808.
|
[6] |
ZHANG Mingkang, MA Yanrong, JIN Yongwen, ZHOU Yan, CUI Ruirui, WU Xin'an.
Advances in clinical research on drug-induced acute interstitial nephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 419-428.
|
[7] |
ZHANG Zhaowei, LI Zuojun, HUANG Jian, LI Shuangqing, HE YiLin.
Exploring the outbreak point for clinical pharmacists to provide pharmaceutical care in nephrology department
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 184-188.
|
[8] |
YU Yahong, SONG Yu.
Pharmacotherapy of patients with left ventricular assist devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 198-204.
|
[9] |
WANG Zhi, ZHOU Xin, HE Xueru, FU Yuhao, XUN Xuejiao, LI Ying, DONG Zhanjun.
Clinical research progress of palbociclib in treatment of breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 205-213.
|
[10] |
ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi.
Interactions and clinical significance of gut microbiota and levothyroxine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314.
|
[11] |
DAI Jiahui, SUN Sijia, XIE Xuefeng.
Quality management and indicator system for clinical trials of medical devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 51-58.
|
[12] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[13] |
SHAO Mingkun, LIU Rong, SUN Pin, GUAN Shui, LIAO Bingcan, LI Sha, CONG Tao, LIANG Kai, MA Hui, SUN Changkai.
Human body networks mechanisms of melatonin and its clinical applications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1031-1040.
|
[14] |
MIAO Yadong, LI Xi, WANG Yan, GAO Po, ZHOU Min, YU Hao.
General considerations for clinical data management of antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1055-1060.
|
[15] |
MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling.
Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
|